GenRx Ranitidine
GenRx Ranitidine - Basic Information
- GN: Ranitidine hydrochloride
- Con: Peptic ulcer disease (pud)
- Cla: information not available
Indication of GenRx Ranitidine:
The use of Ranitidine is indicated in the following conditions: Peptic ulcer diseaseGastro-oesophageal reflux disease HeartburnAction of GenRx Ranitidine:
Ranitidine acts to reduce the production of acid in the stomach.Dose Advice of GenRx Ranitidine:
Peptic Ulcer Disease: The initial recommended dose is 300 mg orally given as a single evening dose for 4-8 weeks or 50 mg intravenously or intramuscularly given every 6-8 hours.Maintenance dosing is 150?300 mg orally given as a single evening dose.Gastro-Oesophageal Reflux Disease: 300 mg orally given as a single evening dose.Prevention of Stress Ulcer: The initial dose is 50 mg intravenously given slowly.An intravenous infusion of 125-250 micrograms/kg/hour should be continued until risk factors for stress ulcer are removed Heartburn: 150 mg orally twice a day for 4-8 weeks.Children2-4 mg/kg orally twice daily up to a maximum dose of 300 mg a day.1 mg/kg intravenously every 6-8 hours up to a maximum dose of 50 mg.Schedule of GenRx Ranitidine:
S4Common side effects of GenRx Ranitidine:
- Headache- Fatigue- Dizziness- Confusion especially in elderly people- Diarrhoea- Constipation- RashUncommon side effects of GenRx Ranitidine:
- Development of breast tissue in males- Decreased libido- Impotence- Reversible involuntary movementDiseases treated by GenRx Ranitidine:
Peptic Ulcer Disease (PUD) Zollinger-Ellison Syndrome (Gastrinoma)GN: Ranitidine hydrochloride
Con: Peptic Ulcer Disease (PUD)